Many patients with pancreatic adenocarcinoma (PDAC) carry germline mutations associated with increased risk of cancer. It is not clear whether patients with intraductal papillary mucinous neoplasms (IPMNs), which are precursors to some pancreatic cancers, also carry these mutations. We assessed the prevalence of germline mutations associated with cancer risk in patients with histologically confirmed IPMN.
You may also like
Marcia Cross of 'Desperate Housewives' Opens Up on Anal Cancer
- April 21, 2019
(MedPage Today) — ActressRead more
GAP Regimen Tops Historical Data for Advanced Biliary Tract Ca
- April 20, 2019
(MedPage Today) — ResultsRead more